Literature DB >> 17460782

IMRT verification using a radiochromic/optical-CT dosimetry system.

Mark Oldham1, Pengyi Guo, Gary Gluckman, John Adamovics.   

Abstract

Year:  2006        PMID: 17460782      PMCID: PMC1855091          DOI: 10.1088/1742-6596/56/1/033

Source DB:  PubMed          Journal:  J Phys Conf Ser        ISSN: 1742-6588


× No keyword cloud information.
  3 in total

1.  Optical-CT gel-dosimetry. II: Optical artifacts and geometrical distortion.

Authors:  Mark Oldham; Leonard Kim
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

2.  Characterization of a new radiochromic three-dimensional dosimeter.

Authors:  P Y Guo; J A Adamovics; M Oldham
Journal:  Med Phys       Date:  2006-05       Impact factor: 4.071

3.  A practical three-dimensional dosimetry system for radiation therapy.

Authors:  Pengyi Guo; John Adamovics; Mark Oldham
Journal:  Med Phys       Date:  2006-10       Impact factor: 4.071

  3 in total
  5 in total

1.  Determination of the depth dose distribution of proton beam using PRESAGE™ dosimeter.

Authors:  L Zhao; I J Das; Q Zhao; A Thomas; J Adamovics; M Oldman
Journal:  J Phys Conf Ser       Date:  2010

2.  A comprehensive evaluation of the PRESAGE/optical-CT 3D dosimetry system.

Authors:  H S Sakhalkar; J Adamovics; G Ibbott; M Oldham
Journal:  Med Phys       Date:  2009-01       Impact factor: 4.071

3.  Commissioning and benchmarking a 3D dosimetry system for clinical use.

Authors:  Andrew Thomas; Joseph Newton; John Adamovics; Mark Oldham
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

4.  Investigation into the feasibility of using PRESAGE/optical-CT dosimetry for the verification of gating treatments.

Authors:  Samuel L Brady; William E Brown; Corey G Clift; Sua Yoo; Mark Oldham
Journal:  Phys Med Biol       Date:  2010-03-26       Impact factor: 3.609

5.  Patient specification quality assurance for glioblastoma multiforme brain tumors treated with intensity modulated radiation therapy.

Authors:  H I Al-Mohammed
Journal:  Int J Med Sci       Date:  2011-08-02       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.